App-Quantinova.ai

Perioperative Mortality and Myocardial Injury Among Patients With Prior High-Risk Cardiac Events Undergoing Non-Cardiac Surgery: A VISON Substudy

Ignacio Garutti - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Four-and-a-Half LIM Domain Protein-2 Absence Reduces Atherogenesis in Apolipoprotein E-deficient Mice: Role of Monocytic Immune Cells

David Simon - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Coronary Artery Disease

ICAM-1

Regulation of Cardiac Fibroblast Phenotype by Scleraxis

Patricia Roche - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

C-Terminal Residues of Phospholamban are Critical Determinants of the Quaternary Structure and Function of the Calcium ATPase Regulatory Complex

Nikolai Smolin - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

saponin

Coronary Artery Disease is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes, and Anemia: An Analysis of the TREAT Trial

Brian Claggett - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Type 2 diabetes mellitus

N/A

When Auto-Antibodies Potentiate: The Paradoxical Signalling Role of Anti-HSP27 Auto-Antibody Immune Complexes Improves Athero-Protection

Yongxiang Chen - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Alkaline phosphatase

Increased Diastolic Untwisting Velocity in Response to Tachycardia as Evidence of Diastolic Reserve in the Young Infant Heart: A Simultaneous Invasive and Noninvasive in vivo Swine Model

Lindsay Mills - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Isoflurane

Left-Atrial Contractile Contribution to Left Ventricle Filling is Preserved in Moderate Chronic Heart Failure

Ian Paterson - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Factors Affecting Fontan Length of Stay: Results From the Single Ventricle Reconstruction Trial

Eric Gerstenberger - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

Rapid Nonsustained Ventricular Tachycardia Detected by Continuous Device Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy: Redefining a Traditional Risk Marker

Adrian M Suszko - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypertrophic cardiomyopathy

N/A

Integrin Linked Kinase is Required for Integrity of Cardiac Ion Current and Electrophysiologic Function

Artak Tadevosyan - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

Relationship Between Appropriateness of Elective Coronary Angiography and Diagnostic Yield for Obstructive Coronary Artery Disease

Feng Qui - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Time-Dependent Interactions of Prasugrel vs Clopidogrel on the Long-Term Risks of Stroke after Acute Coronary Syndromes: Results from the TRILOGY ACS Trial

Benjamin Neely - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Clopidogrel bisulfate

Worsening Heart Failure During Acute Heart Failure Hospitalization: Insights from ASCEND-HF

Robert J Mentz - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congestive heart failure

N/A

Quantitative Analysis of Narrow QRS Peaks Predicts Ventricular Arrhythmic Events in Patients With Hypertrophic Cardiomyopathy

Karthik Viswanathan - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypertrophic cardiomyopathy

N/A

Relationship of Longitudinal Measurements of Biomarkers of Hemodynamic Stress, Systemic Inflammation, and Platelet Reactivity with Ischemic Outcomes in Non-ST-Elevation Acute Coronary Syndrome Patients Managed Without Revascularization

Megan L. Neely - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Clopidogrel bisulfate

Cardiac-specific Deletion of GSK-3? and GSK-3? Leads to Fatal Dilated Cardiomyopathy With Mitotic Catastrophe

Firdos Ahmad - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

MiR-193-3p is Regulated by 4F via Retinoid X Receptor Alpha (RXR-?) and Its Gain Attenuates Proliferation of Pulmonary Artery Smooth Muscle Cells From Pulmonary Arterial Hypertension Patients

Francois Potus - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Tigason

Rate of Carotid Disease Progression in Asymptomatic Low to Moderate Risk Individuals: The Right Study

Christopher T Sibley - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pulmonary arterial hypertension

N/A

The Bromodomain-containing Protein 4: the Epigenetic Origin of the Cancer Paradigm in Pulmonary Arterial Hypertension

Jolyane Meloche - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pulmonary arterial hypertension

Molibresib

Filters

28841 Abstracts